These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23632392)

  • 1. Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.
    Kim SM; Kim HW; Lee EK; Park SK; Han DJ; Kim SB
    Transplantation; 2013 Jul; 96(1):85-90. PubMed ID: 23632392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M; Sharma A; Das A; Chawla Y
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
    Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
    Jain A; Menegus M; Mohanka R; Orloff M; Abt P; Mantry P; Bozorgzadeh A
    Exp Clin Transplant; 2006 Jun; 4(1):475-80. PubMed ID: 16827647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients.
    Töz H; Nart D; Turan I; Ersöz G; Seziş M; Aşçi G; Ozkahya M; Zeytinoğlu A; Erensoy S; Ok E
    Clin Transplant; 2009; 23(5):723-31. PubMed ID: 19573091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
    Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
    Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients.
    Gentil Govantes MA; Esforzado N; Cruzado JM; González-Roncero FM; Balaña M; Saval N; Morales JM
    Transplantation; 2012 Dec; 94(11):1131-7. PubMed ID: 23104249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
    J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression.
    Delladetsima I; Psichogiou M; Sypsa V; Sakellariou S; Hatzakis A; N Boletis J
    Clin Transplant; 2013; 27(1):72-9. PubMed ID: 22994949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
    Orloff SL; Stempel CA; Wright TL; Tomlanovich SJ; Amend WJ; Stock PG; Melzer JS; Vincenti F
    Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
    Wiesner RH
    Hepatology; 2008 Dec; 48(6):1734-6. PubMed ID: 19026008
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.